FDA Inspection 1269423 — QPharma, Inc.
The FDA completed an inspection of QPharma, Inc. on May 6, 2025 in Cedar Knolls, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 6, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cedar Knolls, NJ (United States)